Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Julphar
Colorcon
AstraZeneca
US Army
Chinese Patent Office
UBS
Argus Health
Johnson and Johnson

Generated: November 15, 2018

DrugPatentWatch Database Preview

Genentech Company Profile

« Back to Dashboard

What is the competitive landscape for GENENTECH, and what generic alternatives to GENENTECH drugs are available?

GENENTECH has nine approved drugs.

There are twenty-four US patents protecting GENENTECH drugs.

Drugs and US Patents for Genentech

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genentech Inc ESBRIET pirfenidone CAPSULE;ORAL 022535-001 Oct 15, 2014 RX Yes Yes 8,420,674 ➤ Try a Free Trial Y ➤ Try a Free Trial
Genentech Inc ESBRIET pirfenidone TABLET;ORAL 208780-002 Jan 11, 2017 DISCN Yes No 8,013,002 ➤ Try a Free Trial ➤ Try a Free Trial
Genentech Inc ESBRIET pirfenidone CAPSULE;ORAL 022535-001 Oct 15, 2014 RX Yes Yes 8,084,475 ➤ Try a Free Trial ➤ Try a Free Trial
Genentech Inc ESBRIET pirfenidone TABLET;ORAL 208780-002 Jan 11, 2017 DISCN Yes No 7,816,383 ➤ Try a Free Trial ➤ Try a Free Trial
Genentech NUTROPIN somatropin recombinant INJECTABLE;INJECTION 020168-001 Nov 17, 1993 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Genentech Inc ESBRIET pirfenidone CAPSULE;ORAL 022535-001 Oct 15, 2014 RX Yes Yes 8,648,098 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Genentech

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Genentech NUTROPIN DEPOT somatropin recombinant INJECTABLE;INJECTION 021075-001 Dec 22, 1999 5,912,015 ➤ Try a Free Trial
Genentech NUTROPIN somatropin recombinant INJECTABLE;INJECTION 020168-001 Nov 17, 1993 5,096,885 ➤ Try a Free Trial
Genentech NUTROPIN AQ PEN somatropin recombinant INJECTABLE;INJECTION 020522-002 Apr 22, 2002 5,763,394 ➤ Try a Free Trial
Genentech NUTROPIN DEPOT somatropin recombinant INJECTABLE;INJECTION 021075-003 Dec 22, 1999 6,051,259 ➤ Try a Free Trial
Genentech NUTROPIN DEPOT somatropin recombinant INJECTABLE;INJECTION 021075-002 Dec 22, 1999 5,656,297 ➤ Try a Free Trial
Genentech NUTROPIN DEPOT somatropin recombinant INJECTABLE;INJECTION 021075-002 Dec 22, 1999 6,051,259 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Genentech Drugs

Country Document Number Estimated Expiration
Portugal 2324831 ➤ Try a Free Trial
Brazil 112012014108 ➤ Try a Free Trial
European Patent Office 2343070 ➤ Try a Free Trial
African Regional IP Organization (ARIPO) 3155 ➤ Try a Free Trial
Japan 5678019 ➤ Try a Free Trial
Slovenia 2324831 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Genentech Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
4 Finland ➤ Try a Free Trial
2013024 Lithuania ➤ Try a Free Trial PRODUCT NAME: VISMODEGIBUM; NAT. REGISTRATION NO/DATE: SWISS 62497 01 20130530; FIRST REGISTRATION: EU/1/13/848 20130712
1789390/01 Switzerland ➤ Try a Free Trial PRODUCT NAME: VISMODEGIB; REGISTRATION NO/DATE: SWISSMEDIC 62497 30.05.2013
C0021 France ➤ Try a Free Trial PRODUCT NAME: COBIMETINIB,OPTIONNELLEMENT SOUS TOUTE FORME PROTEGEE PAR LE BREVET DE BASE,NOTAMMENT SES SELS ET SOLVATES PHARMACEUTIQUEMENT ACCEPTABLES,EN PARTICULIER L'HEMIFUMARATE DE COBIMETINIB; REGISTRATION NO/DATE: EU/1/15/1048 20151124
C0002 France ➤ Try a Free Trial PRODUCT NAME: VISMODEGIB AINSI QUE SES SELS ET SOLVATES; NAT. REGISTRATION NO/DATE: EU/1/13/848 20130712; FIRST REGISTRATION: IKS 62497 20130530
90057-6 Sweden ➤ Try a Free Trial PRODUCT NAME: VISMODEGIB OCH SOLVAT DAERAV; NAT. REG. NO/DATE: EU/1/13/848 20130712; FIRST REG.: CH IKS-NR 62497 20130530
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Johnson and Johnson
Deloitte
US Department of Justice
Daiichi Sankyo
Fish and Richardson
Colorcon
Chinese Patent Office
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.